| scholarly article | Q13442814 |
| P50 | author | Quan Zhuang | Q91602152 |
| Ruoyu Ma | Q91602158 | ||
| Yanshuang Yin | Q91602162 | ||
| Tianhao Lan | Q91602169 | ||
| Meng Yu | Q91602173 | ||
| Yingzi Ming | Q91602178 | ||
| P2093 | author name string | Meng Yu | |
| Ruoyu Ma | |||
| Quan Zhuang | |||
| Yingzi Ming | |||
| Tianhao Lan | |||
| Yanshuang Yin | |||
| P2860 | cites work | Current Advance and Future Prospects of Tissue Engineering Approach to Dentin/Pulp Regenerative Therapy | Q26749083 |
| Mesenchymal stem cells: immune evasive, not immune privileged | Q27003371 | ||
| Matrix metalloproteinases in kidney homeostasis and diseases | Q27004621 | ||
| TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation | Q28067425 | ||
| BMP7-induced-Pten inhibits Akt and prevents renal fibrosis | Q47782602 | ||
| Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation. | Q47942466 | ||
| Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury | Q48039370 | ||
| Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies | Q48131162 | ||
| Mesenchymal Stem Cells in Fibrotic Disease | Q48703502 | ||
| Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats. | Q48766708 | ||
| Adipose-derived stem cells ameliorate renal interstitial fibrosis through inhibition of EMT and inflammatory response via TGF-β1 signaling pathway | Q48869471 | ||
| Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production | Q49177880 | ||
| Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus | Q49491394 | ||
| Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury | Q49987830 | ||
| Mechanisms of Renal Fibrosis | Q50081416 | ||
| Renal fibrosis: Primacy of the proximal tubule | Q50097164 | ||
| Placenta Mesenchymal Stem Cell Derived Exosomes Confer Plasticity on Fibroblasts | Q50276791 | ||
| Embryonic stem cell therapy improves bone quality in a model of impaired fracture healing in the mouse; tracked temporally using in vivo micro-CT. | Q50618475 | ||
| Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction. | Q51053705 | ||
| What can target kidney fibrosis? | Q51066092 | ||
| HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing. | Q51072021 | ||
| Icariin combined with human umbilical cord mesenchymal stem cells significantly improve the impaired kidney function in chronic renal failure. | Q51172245 | ||
| [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease]. | Q51768825 | ||
| Human placenta-derived cells have mesenchymal stem/progenitor cell potential. | Q52087798 | ||
| Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy | Q52603651 | ||
| Protective action of bone marrow mesenchymal stem cells in immune tolerance of allogeneic heart transplantation by regulating CD45RB+ dendritic cells. | Q52681872 | ||
| Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB. | Q52780539 | ||
| Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. | Q52786096 | ||
| Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat. | Q53041512 | ||
| Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy. | Q53136407 | ||
| Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury. | Q53170600 | ||
| Adipose tissue-derived stem cell treatment prevents renal disease progression. | Q53187823 | ||
| CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis. | Q53386788 | ||
| Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. | Q54010084 | ||
| Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. | Q54108368 | ||
| The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. | Q54295264 | ||
| Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia. | Q55380290 | ||
| 3D Bioprinted Artificial Trachea with Epithelial Cells and Chondrogenic-Differentiated Bone Marrow-Derived Mesenchymal Stem Cells. | Q55634933 | ||
| Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study | Q56363929 | ||
| Adipose mesenchymal stromal cells: Definition, immunomodulatory properties, mechanical isolation and interest for plastic surgery | Q57168667 | ||
| Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling | Q57168992 | ||
| Adipose-Derived Mesenchymal Stem Cells: A New Tool for the Treatment of Renal Fibrosis | Q57466565 | ||
| Regenerative Medicine Applications of Mesenchymal Stem Cells | Q57776711 | ||
| Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs | Q58765500 | ||
| Cholinergic Nerve Differentiation of Mesenchymal Stem Cells Derived from Long-Term Cryopreserved Human Dental Pulp In Vitro and Analysis of Their Motor Nerve Regeneration Potential In Vivo | Q58768005 | ||
| Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease | Q58782622 | ||
| End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells | Q60182282 | ||
| Mesenchymal stem cell-based therapy in kidney transplantation | Q28069543 | ||
| Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis | Q33556248 | ||
| Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency | Q33605754 | ||
| Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1. | Q33746472 | ||
| Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. | Q33816234 | ||
| Signalling pathways involved in hypoxia-induced renal fibrosis | Q33844658 | ||
| Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy | Q33853514 | ||
| Immunomodulatory properties of stem cells from human exfoliated deciduous teeth | Q33865256 | ||
| Renal pathology and ultrastructural findings in Alport's syndrome | Q34097243 | ||
| The amniotic fluid as a source of cells for fetal tissue engineering | Q34099714 | ||
| Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction | Q34347818 | ||
| Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Q34469147 | ||
| Human adipose tissue derived mesenchymal stem cells aggravate chronic cyclosporin nephrotoxicity by the induction of oxidative stress | Q34651876 | ||
| Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients | Q34753440 | ||
| A clinical approach in regression of glomerulosclerosis | Q34760640 | ||
| Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. | Q34899171 | ||
| The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats | Q35122712 | ||
| Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. | Q35124912 | ||
| The MSC: an injury drugstore | Q35130445 | ||
| Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance | Q35226718 | ||
| Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. | Q35594874 | ||
| Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease | Q35675598 | ||
| Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. | Q35752262 | ||
| Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid. | Q35813514 | ||
| Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury | Q35823993 | ||
| Adipose Tissue-Derived Stem Cells Reduce Acute and Chronic Kidney Damage in Mice. | Q35840626 | ||
| Injection of amniotic fluid stem cells delays progression of renal fibrosis. | Q35853316 | ||
| The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation | Q35878712 | ||
| Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study | Q36246918 | ||
| The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis | Q36510083 | ||
| Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. | Q36838533 | ||
| An abundant perivascular source of stem cells for bone tissue engineering. | Q36861687 | ||
| In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models | Q61978391 | ||
| Cellular and molecular mechanisms of kidney fibrosis | Q62805854 | ||
| Osteogenesis in transplants of bone marrow cells | Q71202383 | ||
| Isolation of mesenchymal stem cells from amniotic fluid and placenta | Q81952730 | ||
| Peritoneal injury by methylglyoxal in peritoneal dialysis | Q83836196 | ||
| Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats | Q86949905 | ||
| Rethinking clinical delivery of adult stem cell therapies | Q87507566 | ||
| Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment | Q88004074 | ||
| Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets | Q88318586 | ||
| Cryptotanshinone Attenuates Oxidative Stress and Inflammation through the Regulation of Nrf-2 and NF-κB in Mice with Unilateral Ureteral Obstruction | Q89419890 | ||
| Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children | Q90449615 | ||
| Osteoblastic differentiation potential of human amniotic fluid-derived mesenchymal stem cells in different culture conditions | Q90760304 | ||
| The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease | Q90809118 | ||
| Plasminogen activator inhibitor-1 and tenascin-C secreted by equine mesenchymal stromal cells stimulate dermal fibroblast migration in vitro and contribute to wound healing in vivo | Q90822672 | ||
| Primate stem cells: bridge the translation from basic research to clinic application | Q90900732 | ||
| HAMSCs/HBMSCs coculture system ameliorates osteogenesis and angiogenesis against glucolipotoxicity | Q90924521 | ||
| Tissue Engineering and Cell-Based Therapies for Fractures and Bone Defects | Q90952457 | ||
| Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion | Q91006938 | ||
| Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety | Q91033339 | ||
| Immune cells and inflammation in AKI to CKD progression | Q91194600 | ||
| Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study | Q36861751 | ||
| Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells | Q36998033 | ||
| Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro | Q36998694 | ||
| Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies | Q36998733 | ||
| The development, structure and blood flow within the umbilical cord with particular reference to the venous system | Q37259591 | ||
| Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. | Q37278443 | ||
| Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow | Q37393107 | ||
| Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats | Q37393439 | ||
| Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury. | Q37545034 | ||
| Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury. | Q37611013 | ||
| The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? | Q37702664 | ||
| Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial | Q38474282 | ||
| Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease | Q38599408 | ||
| TGF-β: the master regulator of fibrosis | Q38816052 | ||
| Gli1+ Pericyte Loss Induces Capillary Rarefaction and Proximal Tubular Injury | Q38821608 | ||
| Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog | Q38824254 | ||
| Role of mesenchymal stem cells in kidney injury and fibrosis. | Q38837260 | ||
| Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia | Q38952815 | ||
| Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair | Q39238366 | ||
| Dental stem cells: recent progresses in tissue engineering and regenerative medicine | Q39398026 | ||
| KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update | Q39535980 | ||
| What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells? | Q41081026 | ||
| Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors | Q41146540 | ||
| Arterially Delivered Mesenchymal Stem Cells Prevent Obstruction-Induced Renal Fibrosis | Q41418374 | ||
| Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis | Q41635867 | ||
| High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. | Q42365746 | ||
| Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation | Q42378467 | ||
| Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. | Q42495926 | ||
| Immature Dental Pulp Stem Cells Showed Renotropic and Pericyte-Like Properties in Acute Renal Failure in Rats | Q42541184 | ||
| Mesenchymal stem cells: a new therapeutic tool for AKI. | Q42650891 | ||
| Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics | Q43423609 | ||
| Distribution of infused umbilical cord mesenchymal stem cells in a rat model of renal interstitial fibrosis | Q44346380 | ||
| Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy | Q44535588 | ||
| Exosomes as biomimetic tools for stem cell differentiation: Applications in dental pulp tissue regeneration | Q44902676 | ||
| Human Umbilical Cord-Derived Mesenchymal Stem Cells Conditioned Medium Attenuate Interstitial Fibrosis and Stimulate the Repair of Tubular Epithelial Cells in an Irreversible Model of Unilateral Ureteral Obstruction | Q46341874 | ||
| Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study | Q46853630 | ||
| Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats | Q46937050 | ||
| Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2/M cell cycle arrest | Q47390427 | ||
| Defining the risks of mesenchymal stromal cell therapy | Q47584701 | ||
| Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. | Q47605121 | ||
| Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro | Q47658096 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| renal fibrosis | Q18553516 | ||
| P304 | page(s) | 8387350 | |
| P577 | publication date | 2019-01-13 | |
| P1433 | published in | Stem Cells International | Q26842114 |
| P1476 | title | Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy | |
| P478 | volume | 2019 |
| Q101476239 | Effect and mechanism of human umbilical cord mesenchymal stem cells in treating allergic rhinitis in mice |
| Q94550257 | Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation |
| Q94544716 | The whole-transcriptome landscape of muscle and adipose tissues reveals the ceRNA regulation network related to intramuscular fat deposition in yak |
Search more.